Pfizer breast cancer drug gets early FDA approval

Federal health regulators have approved a highly anticipated medicine from Pfizer Inc to treat postmenopausal women with a certain type of advanced breast cancer who have not already taken other drugs.

Birth control pills recall raises risk of unplanned pregnancy

Pfizer Inc is reaching out directly to women consumers to warn them about its US recall of one million packets of birth control pills.